Stay updated with breaking news from Casi long. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 price objective on shares of CASI Pharmaceuticals in a research report on Monday, […] ....
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $10.00 price objective on shares of CASI Pharmaceuticals in a research report on Monday, August 14th. […] ....
StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a report released on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of CASI Pharmaceuticals in a research note on Monday, August […] ....
StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 price objective on shares of CASI Pharmaceuticals in a research note on […] ....
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a report issued on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $10.00 price target on shares of CASI Pharmaceuticals in a research note on Monday, August 14th. […] ....